Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
164.83
+4.00 (2.49%)
Dec 20, 2024, 4:00 PM EST - Market closed
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $4.74 billion as of December 20, 2024. Its market cap has increased by 62.54% in one year.
Market Cap
4.74B
Enterprise Value
4.05B
1-Year Change
62.54%
Ranking
Category
Stock Price
$164.83
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $102.60M to $4.74B, an increase of 4,520.28%. That is a compound annual growth rate of 69.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.18B |
| BridgeBio Pharma | 5.02B |
| Crinetics Pharmaceuticals | 4.95B |
| Alkermes | 4.87B |
| Viking Therapeutics | 4.84B |
| TG Therapeutics | 4.64B |
| Integer Holdings | 4.49B |
| Axsome Therapeutics | 4.46B |